IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer Patients

Ziming Yuan,1 Zhixun Zhao,2 Hanqing Hu,1 Yihao Zhu,1 Weiyuan Zhang,1 Qingchao Tang,1 Rui Huang,1 Feng Gao,1 Chaoxia Zou,3 Guiyu Wang,1 Xishan Wang1,2 1Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China; 2Departm...

Full description

Bibliographic Details
Main Authors: Yuan Z, Zhao Z, Hu H, Zhu Y, Zhang W, Tang Q, Huang R, Gao F, Zou C, Wang G, Wang X
Format: Article
Language:English
Published: Dove Medical Press 2021-02-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/igg-fc-binding-protein-fcgbp-is-down-regulated-in-metastatic-lesions-a-peer-reviewed-article-OTT
id doaj-73031dc7133d4720a94dae69e2b2b88a
record_format Article
spelling doaj-73031dc7133d4720a94dae69e2b2b88a2021-02-14T19:42:01ZengDove Medical PressOncoTargets and Therapy1178-69302021-02-01Volume 1496797761963IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer PatientsYuan ZZhao ZHu HZhu YZhang WTang QHuang RGao FZou CWang GWang XZiming Yuan,1 Zhixun Zhao,2 Hanqing Hu,1 Yihao Zhu,1 Weiyuan Zhang,1 Qingchao Tang,1 Rui Huang,1 Feng Gao,1 Chaoxia Zou,3 Guiyu Wang,1 Xishan Wang1,2 1Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China; 2Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 3Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang, People’s Republic of ChinaCorrespondence: Xishan Wang Email wxshan_1208@126.comGuiyu Wang Email guiywang@163.comBackground: The liver is the most frequent site for metastatic spread in colorectal cancer (CRC) patients, and these patients have much poorer prognosis than those without metastasis. Previous studies have shown that IgG Fc binding protein (FCGBP) plays important roles in tumorigenesis, progression, and prognosis, but its role in CRC metastasis remains unclear.Purpose: In this study, we are aimed to explore the significance of FCGBP in liver metastatic CRC (LMCRC) patients.Methods: We analyzed the expression of FCGBP RNA between CRC primary samples and liver metastatic samples in the Gene Expression Omnibus (GEO) database and The Cancer Genome Atlas (TCGA). Next, we assessed the expression of FCGBP protein in 135 paired primary CRC (PC) samples and LMCRC samples. Finally, we explored the relationship between the expression features and clinicopathological characteristics.Results: The expression data of FCGBP were obtained from the GEO and TCGA databases. FCGBP RNA expression was evaluated between primary lesions (PC) and liver metastatic lesions (LM). FCGBP RNA was down-regulated in PC and LM, and especially lower in LM (p< 0.001). Next, the expression of FCGBP protein was evaluated by an immunohistochemistry array in 135 paired primary tumor tissues and metastatic tissues. We found that FCGBP protein was down-regulated in primary lesions and metastatic lesions, especially in metastatic lesions. According to the immunohistochemistry score (SI), each cohort was divided into FCGBP-positive (SI=4– 12) and FCGBP-negative (SI=0– 3) groups. In both groups, the levels of CEA (PC group, 3.880 vs 77.049, p< 0.001; LM group, 3.890 vs 14.239, p=0.008) and CA19-9 (PC group, 8.610 vs 111.700, p< 0.001; LM group, 7.660 vs 19.380, p=0.037) were lower than those in the FCGBP-negative group. FCGBP positivity in the LM cohort was an independent risk factor in both overall survival (HR 1.573, 95% Cl [1.017– 2.433], p=0.042) and disease-free survival (HR 1.869, 95% Cl [1.256– 2.781], p=0.002).Conclusion: This study found a relationship between FCGBP expression and clinical information of LMCRC patients, and found that FCGBP expression decreased with disease development. The expression of FCGBP in liver metastasis is associated with both the overall and progression-free survival. Our results show that FCGBP could be a promising prognostic factor for LMCRC.Keywords: colorectal cancer, IgG Fc binding protein, liver metastasis, prognosis, biomarkerhttps://www.dovepress.com/igg-fc-binding-protein-fcgbp-is-down-regulated-in-metastatic-lesions-a-peer-reviewed-article-OTTcolorectal cancerigg fc binding proteinliver metastasisprognosisbiomarker
collection DOAJ
language English
format Article
sources DOAJ
author Yuan Z
Zhao Z
Hu H
Zhu Y
Zhang W
Tang Q
Huang R
Gao F
Zou C
Wang G
Wang X
spellingShingle Yuan Z
Zhao Z
Hu H
Zhu Y
Zhang W
Tang Q
Huang R
Gao F
Zou C
Wang G
Wang X
IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer Patients
OncoTargets and Therapy
colorectal cancer
igg fc binding protein
liver metastasis
prognosis
biomarker
author_facet Yuan Z
Zhao Z
Hu H
Zhu Y
Zhang W
Tang Q
Huang R
Gao F
Zou C
Wang G
Wang X
author_sort Yuan Z
title IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer Patients
title_short IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer Patients
title_full IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer Patients
title_fullStr IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer Patients
title_full_unstemmed IgG Fc Binding Protein (FCGBP) is Down-Regulated in Metastatic Lesions and Predicts Survival in Metastatic Colorectal Cancer Patients
title_sort igg fc binding protein (fcgbp) is down-regulated in metastatic lesions and predicts survival in metastatic colorectal cancer patients
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2021-02-01
description Ziming Yuan,1 Zhixun Zhao,2 Hanqing Hu,1 Yihao Zhu,1 Weiyuan Zhang,1 Qingchao Tang,1 Rui Huang,1 Feng Gao,1 Chaoxia Zou,3 Guiyu Wang,1 Xishan Wang1,2 1Department of Colorectal Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China; 2Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China; 3Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin, Heilongjiang, People’s Republic of ChinaCorrespondence: Xishan Wang Email wxshan_1208@126.comGuiyu Wang Email guiywang@163.comBackground: The liver is the most frequent site for metastatic spread in colorectal cancer (CRC) patients, and these patients have much poorer prognosis than those without metastasis. Previous studies have shown that IgG Fc binding protein (FCGBP) plays important roles in tumorigenesis, progression, and prognosis, but its role in CRC metastasis remains unclear.Purpose: In this study, we are aimed to explore the significance of FCGBP in liver metastatic CRC (LMCRC) patients.Methods: We analyzed the expression of FCGBP RNA between CRC primary samples and liver metastatic samples in the Gene Expression Omnibus (GEO) database and The Cancer Genome Atlas (TCGA). Next, we assessed the expression of FCGBP protein in 135 paired primary CRC (PC) samples and LMCRC samples. Finally, we explored the relationship between the expression features and clinicopathological characteristics.Results: The expression data of FCGBP were obtained from the GEO and TCGA databases. FCGBP RNA expression was evaluated between primary lesions (PC) and liver metastatic lesions (LM). FCGBP RNA was down-regulated in PC and LM, and especially lower in LM (p< 0.001). Next, the expression of FCGBP protein was evaluated by an immunohistochemistry array in 135 paired primary tumor tissues and metastatic tissues. We found that FCGBP protein was down-regulated in primary lesions and metastatic lesions, especially in metastatic lesions. According to the immunohistochemistry score (SI), each cohort was divided into FCGBP-positive (SI=4– 12) and FCGBP-negative (SI=0– 3) groups. In both groups, the levels of CEA (PC group, 3.880 vs 77.049, p< 0.001; LM group, 3.890 vs 14.239, p=0.008) and CA19-9 (PC group, 8.610 vs 111.700, p< 0.001; LM group, 7.660 vs 19.380, p=0.037) were lower than those in the FCGBP-negative group. FCGBP positivity in the LM cohort was an independent risk factor in both overall survival (HR 1.573, 95% Cl [1.017– 2.433], p=0.042) and disease-free survival (HR 1.869, 95% Cl [1.256– 2.781], p=0.002).Conclusion: This study found a relationship between FCGBP expression and clinical information of LMCRC patients, and found that FCGBP expression decreased with disease development. The expression of FCGBP in liver metastasis is associated with both the overall and progression-free survival. Our results show that FCGBP could be a promising prognostic factor for LMCRC.Keywords: colorectal cancer, IgG Fc binding protein, liver metastasis, prognosis, biomarker
topic colorectal cancer
igg fc binding protein
liver metastasis
prognosis
biomarker
url https://www.dovepress.com/igg-fc-binding-protein-fcgbp-is-down-regulated-in-metastatic-lesions-a-peer-reviewed-article-OTT
work_keys_str_mv AT yuanz iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
AT zhaoz iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
AT huh iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
AT zhuy iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
AT zhangw iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
AT tangq iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
AT huangr iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
AT gaof iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
AT zouc iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
AT wangg iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
AT wangx iggfcbindingproteinfcgbpisdownregulatedinmetastaticlesionsandpredictssurvivalinmetastaticcolorectalcancerpatients
_version_ 1724269517918437376